Ardigen | Data & AI Engineering for Drug Discovery and Development https://validator.w3.org/feed/docs/rss2.html Biomedical knowledge graph demo Data Universe AI Phenotypic Profiling for Hit Prioritization Next-Generation Tools in Drug Discovery Łukasz Nowak How Agentic AI is closing the loop in drug discovery ardigen.com/events/networking-basel-october-2026 Phenotypic Profiling & Screening, Ardigen phenAID AI-ready data products Agentic AI development services AI Protein Binder Design Case Study AI Target Discovery from Multimodal Data Target Identification and Validation Services AI for Small Molecule Drug Discovery AI for Clinical Trials and Clinical Drug Development Knowledge graph implementation AI Biologics Development Services Foundation Models in Drug Discovery: What Pharma Needs to Scale Multimodal AI Data Governance in Drug Discovery: Designing Audit-Ready Storage for Regulated R&D The AI-Biology Convergence: Designing the Next Generation of Biologics Ardigen and VERAXA Biotech announce AI-enabled drug discovery collaboration Data Privacy Policy Poster: Bridging the Phenotype-Proteome Gap: A Multi-Modal AI Framework for analysis of Cell Painting images Finding responders with multimodal fusion of histology and clinical data The invisible bridge: How UX design can support AI success in bioinformatics? Real-time analytics for Clinical Trials Multimodal data integration for machine learning project Predicting gene essentiality from omics data Leveraging biomarkers to bring the right treatment to the right patient Latest progress and tools for de novo generation of peptides Antibody Hit Screening: Developing Successful Therapies with the Help of In Silico Tools From bulk to spatial: How transcriptomics is changing the way we see biology Can You Trust Your Model? Why Explainability Matters in AI-Driven Drug Discovery Foundational Models for AI in Biology Uncovering novel targets and approaches to treating neurological diseases Transforming clinical trial reporting: A scalable and compliant data platform The 49% Problem: Why Closing the Lab-AI Loop Starts Beneath the Iceberg The Scaling Paradox: Why Adding More Cloud Resources in Bioinformatics Doesn’t Always Solve the Problem From patient data to novel targets and biomarkers: UK Biobank use What type of data do you need for AI Drug Discovery? AI-Driven De Novo Generation of Protein Binders Unlock biological insights in populational proteomics dataset Unveiling the Parkinson’s Disease microbiome signature Scaling AI in Life Sciences: Why Data Infrastructure Determines Success Homepage Large Language Model platform for patient-friendly content What’s trending in European Biopharma? A look ahead Where AI Meets Wet-Lab: A Smarter Path to Biologics Discovery Success The Applications of Morphological Profiling for Drug Discovery: The success stories Knowledge hub